Tiny sensor tracks sugar spikes in breast cancer drug study
NCT ID NCT06083038
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study looked at how a drug called alpelisib affects blood sugar in people with metastatic breast cancer. Eight patients wore a continuous glucose monitor for months to track sugar levels day and night. The goal was to better understand and manage high blood sugar, a common side effect of the drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
HealthPartners Cancer Research Center
Saint Louis Park, Minnesota, 55426, United States
Conditions
Explore the condition pages connected to this study.